How have MYMX shares performed in 2024?

Mymetics' stock was trading at $0.0020 at the start of the year. Since then, MYMX shares have increased by 400.0% and is now trading at $0.01. View the best growth stocks for 2024 here .

What other stocks do shareholders of Mymetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mymetics investors own include Genocea Biosciences (GNCA) , Dynavax Technologies (DVAX) , Fujitsu (FJTSY) , Himax Technologies (HIMX) , Maxar Technologies (MAXR) , Revance Therapeutics (RVNC) , Boeing (BA) , Activision Blizzard (ATVI) , Asure Software (ASUR) and Arlo Technologies (ARLO) .

How do I buy shares of Mymetics?

Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MYMX

Mymetics (MYMX) Stock Price, News & Analysis

→ Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad)

Free MYMX Stock Alerts

$0.01

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.01
▼
$0.01
50-Day Range: $0.01
▼
$0.26
52-Week Range: $0.01
▼
$70.00

Volume: 1 shs
Average Volume: N/A
Market Capitalization: $1,500.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings

Get Mymetics alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Mymetics

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, malaria, and chikungunya. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; PATH Malaria Vaccine Initiative and the Laboratory of Malaria Immunology and Vaccinology of the National Institute of Allergy and Infectious Diseases to develop and produce virosome based vaccine formulations for a malaria transmission-blocking vaccine candidate; and Sanofi Pasteur Biologics, LLC to investigate the immunogenicity of influenza vaccines. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

MYMX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MYMX Stock News Headlines

March 29, 2024 | seekingalpha.com

PLTXF PlantX Life Inc.

February 2, 2024 | finance.yahoo.com

Mymetics Corporation (MYMXD) Stock Historical Prices & Data - Yahoo Finance

April 18, 2024 | Timothy Sykes (Ad)

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

December 31, 2023 | benzinga.com

Mymetics Stock (OTC:MYMX) Dividends: History, Yield and Dates

March 1, 2023 | lse.co.uk

Oriole Resources project in Cameroon delivers high-grade gold results

November 16, 2022 | benzinga.com

Mymetics Stock (OTC:MYMX), Short Interest Report

October 11, 2022 | finance.yahoo.com

Mymetics Corporation (MYMX)

September 1, 2022 | seekingalpha.com

Mymetics, PCI Biotech team up for preclinical research on cancer therapy

April 18, 2024 | Timothy Sykes (Ad)

Urgent alert: open this for a huge profit potential

This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.

September 1, 2022 | finanznachrichten.de

Mymetics Corporation: Mymetics and PCI Biotech Sign a Preclinical Research Collaboration

August 31, 2022 | finance.yahoo.com

Mymetics and PCI Biotech Sign a Preclinical Research Collaboration

August 25, 2022 | reuters.com

MYMX.PK - Mymetics Corp | Stock Price & Latest News | Reuters

See More Headlines

Receive MYMX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mymetics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/18/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: OTCMKTS:MYMX
CUSIP: N/A
CIK: 927761
Web: www.mymetics.com
Phone: (121) 653-4535
Fax: 41-21-653-2473
Employees: 2
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,060,000.00
Net Margins: -1,914.40%
Pretax Margin: -1,917.46%
Return on Equity: N/A
Return on Assets: -128.84%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.08 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.23) per share
Price / Book: -0.04

Miscellaneous

Outstanding Shares: 150,000
Free Float: 144,000
Market Cap: $1,500.00
Optionable: Not Optionable
Beta: 1.74

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Ronald Kempers (Age 56)
CEO, COO, President & CFO
Comp: $303.83k
Mr. Mario Amacker Ph.D.
Head of Quality & Manufacturing

Key Competitors

View All Competitors

MYMX Stock Analysis - Frequently Asked Questions

How have MYMX shares performed in 2024?: Mymetics' stock was trading at $0.0020 at the start of the year. Since then, MYMX shares have increased by 400.0% and is now trading at $0.01.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Mymetics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Mymetics investors own include Genocea Biosciences (GNCA), Dynavax Technologies (DVAX), Fujitsu (FJTSY), Himax Technologies (HIMX), Maxar Technologies (MAXR), Revance Therapeutics (RVNC), Boeing (BA), Activision Blizzard (ATVI), Asure Software (ASUR) and Arlo Technologies (ARLO).
How do I buy shares of Mymetics?: Shares of MYMX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MYMX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial